For any inquiries regarding sponsorships, the exhibition or your custom-made promotional proposal please contact
Mr. George Lasithiotakis or Mr. Alexandros Terzis
by email at gla@era.gr or aterzis@era.gr.
AJL Ophthalmic, S.A. is the only Spanish company (July 1992) dedicated to the r&D, manufacture and marketing of medical devices in the field of Ophthalmology.
The company has reached a leading market postion thanks to the fulfillment of very exigent Regulatory and Quality Control Requirements, 3000 m2 facilities with cutting-edge tecnology as well as the most qualified personnel for the manufacture of its products.
AJL has an extensive sales network with presence in more than 80 countries.
Mediphacos is a world-class company with over 50 years of experience in ophthalmology and presence in more than 60 countries in 5 continents. Our mission is to restore, preserve and improve human vision in collaboration with ophthalmologists through innovative, safe and effective products and services. Products featured: KERARING – intracorneal rings for corneal ectatic disorders, BIOS – trifocal IOLs, INTRALENS – posterior chamber phakic IOLs and more.
Regensight is introducing a revolutionary paradigm shift in keratoconus treatment based upon theranostics, which involves the integration of diagnostic and therapeutic capabilities within a single platform.
The integration of theranostics in C4V CHROMO4VIS device exploits simultaneous UV-A light mediated fluorescence imaging technique for assessing riboflavin concentration and enables targeted UV-A light photo-activation of the substance with predictive personalization of therapeutic outcome. The multicenter randomized ARGO clinical trial demonstrated that integrating theranostics in C4V CHROMO4VIS for treatment of keratoconus achieved 91% accuracy and 95% precision in predicting Kmax flattening at 1-year follow-up.
The C4V CHROMO4VIS device further incorporates AI and IoMT technologies that make the device more efficient with eye surgeons’ use.